HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

O- beta- ribosyl(1''- - 2')adenosine- 5''- phosphate

structure given in first source

Also Known As:

R-AMP

Networked: 9 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purine Nucleotides: 140
        Adenine Nucleotides: 1066
        Adenosine Monophosphate: 5507
        O-beta-ribosyl(1''--2')adenosine-5''-phosphate: 9
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleotides: 15763
  - Ribonucleotides: 307
    - Adenine Nucleotides: 1066
      - Adenosine Monophosphate: 5507
        O-beta-ribosyl(1''--2')adenosine-5''-phosphate: 9
  - Purine Nucleotides: 140
    - Adenine Nucleotides: 1066
      - Adenosine Monophosphate: 5507
        O-beta-ribosyl(1''--2')adenosine-5''-phosphate: 9

Experts

1.	Kang, Wonki: 1 article (01/2021)
2.	Kim, Won Jae: 1 article (01/2021)
3.	Dent, Jennifer: 1 article (01/2019)
4.	Graef, Katy M: 1 article (01/2019)
5.	Hargan-Calvopiña, Joseph: 1 article (01/2019)
6.	Manner, Cathyryne K: 1 article (01/2019)
7.	Weber, Callie J: 1 article (01/2019)
8.	Steffen, Julius Alexander: 1 article (03/2014)

Related Diseases

1.	Esotropia (Esophoria) 01/01/2021 - "This study aimed to evaluate the surgical outcomes of unilateral medial rectus recession and lateral rectus resection (R&R) for patients with large-angle deviations of acute acquired concomitant esotropia (AACE) without a neurological disease. "
2.	Cognitive Dysfunction 05/01/2023 - "The participants were recruited as part of a prospective, community-based cohort study for MCI (PREcision medicine platform for mild cognitive impairment on multi-omics, imaging, evidence-based R&BD; PREMIER). "
3.	Neglected Diseases 01/09/2019 - "As a platform for public-private partnerships (PPPs), the WIPO Re:Search consortium engages the private sector in early-stage R&D for neglected diseases by forging mutually beneficial collaborations and facilitating the sharing of intellectual property (IP) assets between the for-profit and academic/non-profit sectors. "
4.	Pulmonary Tuberculosis 07/01/1968 - "[Clinical use of rifampicin (R-AMP) in chronic pulmonary tuberculosis]."
5.	Schistosomiasis (Bilharziasis) 01/09/2019 - "However, research and development (R&D) to develop new approaches to preventing, diagnosing, and treating schistosomiasis has been relatively limited. "

Related Drugs and Biologics

1.	Rifampin (Rifampicin)

Related Therapies and Procedures

1.	Precision Medicine
2.	Debridement